top of page

Search Results

Results found for "Timo De Groof"

  • 📰 GPCR Weekly News, May 8 to 14, 2023

    If you're interested in presenting a poster, there's still time. Therapeutics in the 23rd BioEquity Europe Conference Simon Bekker-Jensen and Mette M Rosenkilde received two proof

  • 📰 GPCR Weekly News - January 9 to 15, 2023

    Industry News Trevena Enrolls First Subject in TRV045 Proof-of-Concept Trial Evaluating S1PR Mechanism

  • 📰 GPCR Weekly News, October 16 to 22, 2023

    surface protein in yeast cells Trevena Reports Favorable TRV045 Topline Safety and Tolerability Data from Proof-of-Concept

  • A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.

    Homogeneous Time-Resolved Fluorescence (HTRF) is a TR-FRET-based assay[16] conducted in homogeneous conditions (12)      Martín-Fontecha, M.; Angelina, A.; Rückert, B.; Rueda-Zubiaurre, A.; Martín-Cruz, L.; Van De Time-Resolved Detection of Energy Transfer: Theory and Application to Immunoassays. Cell-Surface Protein-Protein Interaction Analysis with Time-Resolved FRET and Snap-Tag Technologies:

  • Regulators of G-protein signaling: essential players in GPCR signaling

    in their structural complexity, some members of the RGS family are selective for certain GPCRs, as a proof

  • Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools

    Discover how Revvity’s pHSense™ reagents enable real-time GPCR internalization detection A breakthrough challenges in GPCR internalization assays , pHSense™ reagents  combine live-cell, no-wash protocols  with time-resolved fluorescence (TRF) detection , enabling real-time detection of GPCR internalization —without microscopy detecting endogenous GPCRs With pHSense™, scientists can finally track GPCR internalization  in real time—even GPCR Podcast , where he shares the story behind pHSense , including its application in real-time internalization

  • Knowing When to Walk, Knowing When to Run: Lessons from the Bench

    But over time, he’s learned a skill that transformed his career: pacing. Some weeks, the best use of your time is reading, thinking, and slowing down. Other times, you’ll need to sprint. Knowing the difference is survival.

  • From Pipettes to Platforms: The Evolution of GPCR Research

    Watch Episode 176 The first time Michelle ran a cyclic AMP assay, she did it with a single-channel pipette That’s not a story about nostalgia — it’s a snapshot of how GPCR research was built, on technique at a time We were doing assays on ice, pipetting one sample at a time. result, The pace and precision of GPCR research today — from high-throughput ligand screens to real-time Like many, it was a mix of opportunity, timing, and the courage to say yes before everything was figured

  • From Student to Mentor: What Alessandro Nicoli Learned About Leading in Science

    it was difficult, because you see all these projects and you think, ah, I don’t know… but then with time —Alessandro Nicoli He discovered that investing time in people pays off. But at the same time, you pass the same struggle before… you shape the new generation too.”  

  • Glyco-sulfo hotspots in the chemokine receptor system

    post-translational modifications (PTMs), contribute to the high affinity binding to the positively charged groove

  • The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts

    And every time your Head of Biology spends each night copy-pasting data instead of thinking about the next experiment, your program is bleeding six figures in lost time and wasted salaries. But here’s the reality: even ultra-specialized experts can’t fix systemic dysfunction in their spare time That’s a chaos tax — and you’re paying it in cash, time, and morale.

  • Advantages of Fluorescent Probes in GPCR Assays

    Fluorescent ligands provide real-time data on receptor activation, ligand binding and downstream signaling Real-time dynamic labeling of A 2B AR. confocal images of HCT116 cells pre-stained with CellTracker Green (lower panels) and labeled in real-time C) Quantification of CELT-327 average fluorescence intensity over time. when prolonged exposure to light in the excitation range causes the emission signal to decrease over time

  • The Chemistry of Confidence: Aha Moments That Shape Scientific Careers

    “The first time I wore my lucky cactus shirt to a major meeting... and it led to a game-changing collaboration Getting accepted into a PhD program during a personally difficult time.

  • How to Avoid the Most Common Gaps in Your Biotech Pitch

    And most of the time, the issue isn’t style. If your pitch doesn’t address timing, portfolio alignment, or internal traction, the audience won’t do it addresses. ✅ Frame the situation in terms of what’s at stake, whether that’s patient outcomes, time It’s about strategic clarity. ✅ When your pitch follows this logic, it respects the listener’s time, It communicates that you know who you’re building for, why now is the right time, and how your solution

  • From Technician to Trailblazer: How Sokhom Pin Designed His Own PhD Program While Working in Industry

    Watch Episode 169 What if you could earn a PhD while supporting a family and working full time in drug With a growing family and a full-time position, traditional PhD training just wasn’t an option.

  • The Five Traps of Ignoring Kinetics

    potency errors from premature reads ✅ Methods to detect hidden mechanisms—mixtures, dual effects, or time-dependent catching a train: two passengers have tickets (affinity), but only the one who sprints to the platform on time But that’s timing, not a different kind of corn. That’s not pharmacology. That’s kinetics. activities before they waste resources Classify antagonists by offset rate without waiting on PK data Spot time-dependent

  • New Tools, Smart Signals, and The Kenakin Brief

    The time you’ll save is yours. Terry’s Corner is coming soon. Dr. The time you’ll save is yours. Terry’s Corner is coming soon. Stay curious, The Dr. GPCR Team

  • Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal

    Early In Vivo Wins the Race When is the right time to move beyond cell assays? “Target residence time in vivo correlates beautifully with activity. Modern real-time assays can deliver these insights earlier, faster, and cheaper than most teams assume Every misaligned study is not just wasted budget—it’s lost time. Program Kill vs.

  • Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands..

    kinetics-based drug development have become immensely interested in predicting the drug target residence time Screening drug candidates in terms of their computationally predicted residence times, which is a measure from steered molecular dynamics simulations and the Bell-Evans model to predict the absolute residence times We have predicted the absolute ligand residence times on the timescale of seconds.

  • Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining

    staining is a technique that helps differentiate cells and has been used in flow cytometry for a long time This facilitates the study of receptor dynamics, ligand binding and signaling in real time. the advantages enumerated previously, fluorescent ligands provide new capabilities: -            Real time

  • Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon

    and early safety in real development contexts Advance with nuanced lessons on allostery, residence time Read how scientific need and timing drove the leap from academia to application.  

  • Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling

    Bioluminescence Resonance Energy Transfer (BRET), has revolutionized the study of GPCRs by enabling real-time One of the significant advantages of FRET and BRET-based sensors is their ability to provide real-time discovery efforts by enabling the precise characterization of pharmacological interventions in real time Galés, C., et al., Real-time monitoring of receptor and G-protein interactions in living cells.  Eidne, Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein

  • Understanding the Journey: Catherine Demery's Path to Addiction Science

    Learning the Lab, Learning Herself During her time at the contract research organization (CRO) in Ann that would reshape her academic ambitions. “...I had a light bulb moment where I felt for the first time For the first time, she saw herself as a future researcher, not just a technician or a student.

  • Exclusive Access: Terry's Corner is LIVE + Your Premium Member Discount!

    GPCR Premium Members a significantly reduced access  to Terry's Corner for a limited time.  

  • Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization

    Separate effect size from time:  Use allosteric modulators to expand therapeutic index and reduce overdose The Advantages Live-cell imaging:  visualize receptor–ligand interactions in real time, without disturbing Why It Matters In the CNS, where receptor localization and real-time signaling shape therapeutic outcomes Access this week’s full Premium Edition here ➤ What our members say "This came at just the most perfect time

  • From Ox Liver to AI: How the History of Pharmacology Shapes Its Future

    Whether you're stepping into pharmacology for the first time or rekindling your interest, this lesson

  • Beyond the Probe: Scaling Innovation From the Bench to Product Launch

    positions, tailor activity (agonist or antagonist), and retain biological function, all while skipping the time-consuming

  • From GPCR Data Chaos to Decisive Action

    Real-Time Global Insight As founder of Dr. Even strong science stalls without operational structure ✅ Scattered data = missed insights = wasted time

  • Science Needs Rigor, But Also Joy

    Watch Episode 166 When’s the last time you argued in the lab about injecting GTPγS?

  • 📰 GPCR Weekly News, April 29 to May 5, 2024

    If you aren't joining us this time, stay tuned for more Dr. GPCR University content coming soon.

bottom of page